Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01741636 · ClinicalTrials.gov registry record · NA

Survivorship Care Planning in Patients With Colorectal or Non-Small Cell Lung Cancer

A NA study, sponsored by City of Hope Medical Center.

Completed
Registry status
NA
Development phase
30
Enrollment target

NCT01741636: Completed NA study, sponsored by City of Hope Medical Center.

NCT01741636 is a NA study that has completed, run by City of Hope Medical Center. The registered enrollment target is 30 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01741636, a NA study, has completed, sponsored by City of Hope Medical Center.

COMPLETED
Registry status
NA
Development phase
30 participants
Enrollment target

Study Summary

Survivorship Care Planning may improve overall well-being and quality of life of colorectal and lung cancer survivors

Primary Outcome

Descriptive statistics will be presented on those who agree to participate and the proportion of those approached who agree to participate.

Interventions

  • OTHER questionnaire administration
  • PROCEDURE quality-of-life assessment
  • OTHER educational intervention

Trial Details

FieldValue
Enrollment Target 30 participants
Start Date 2013-01
Est. Completion 2013-12
Phase NA
City of Hope Medical Center

582 total trials

What the finished NCT01741636 record still lists

NCT01741636 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).

The record links to 0 conditions, and to 3 interventions - of which questionnaire administration is the first listed.

NCT01741636 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01741636 about?

NCT01741636 is a clinical study titled "Survivorship Care Planning in Patients With Colorectal or Non-Small Cell Lung Cancer". Survivorship Care Planning may improve overall well-being and quality of life of colorectal and lung cancer survivors

What is the current status of trial NCT01741636?

This trial is currently completed. It is a NA study. The enrollment target is 30 participants. The study started on 2013-01. Estimated completion is 2013-12.

What interventions are being tested in trial NCT01741636?

The interventions under investigation include: questionnaire administration (OTHER), quality-of-life assessment (PROCEDURE), educational intervention (OTHER).

Who is sponsoring clinical trial NCT01741636?

This trial is sponsored by City of Hope Medical Center, which has 582 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT01741636's enrollment target sits among peer trials

30 1593rd of 2000 higher than 299 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00977977 · 30 participants · Phase 2

    Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy

  • NCT01459107 · 30 participants · Phase 2

    Human Upper Extremity Allotransplantation

  • NCT01666080 · 30 participants · NA

    Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)

  • NCT01720836 · 30 participants · Phase 1

    Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01741636, the US trial registry maintained by the National Library of Medicine. NCT01741636 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.